Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miloje Savic

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2014
Molecular recognition and modification of the 30S ribosome by the aminoglycoside-resistance methyltransferase NpmAJack A Dunkle, Kellie Vinal, Pooja M Desai, et al.
The Journal of Antibiotics|September 15, 2011
New polyene macrolide family produced by submerged culture of Streptomyces durmitorensisEva Stodůlková, Marek Kuzma, Ivana Bratic Hench, et al.
The Lancet. Global Health|April 27, 2025
Incidence rates of malaria, meningitis, and mortality in children younger than 5 years: a prospective cohort study in Ghana and Kenya before the roll-out of the RTS,S/AS01<sub>E</sub> malaria vaccine from 2016 to 2022Kwaku Poku Asante, Marie-Cécile Bozonnat, Miloje Savic, et al.
Eclinicalmedicine|May 4, 2026
Feasibility, accuracy, and effect of a rapid point-of-care serological test (SeroSelectTB) to identify presumptive pulmonary TB patients for confirmatory testing in Ethiopia, South Africa, and Tanzania: a multicenter, open-label, parallel-group, randomized, controlled trialMiloje Savic, Grant Theron, Kidist Bobosha, et al.
The Lancet. Global Health|November 9, 2025
Effectiveness of the RTS,S/AS01<sub>E</sub> malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and MalawiLatif Ndeketa, Valérie Haine, Muriel Debois, et al.
The Lancet. Global Health|April 27, 2025
Safety of RTS,S/AS01<sub>E</sub> malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring studyValérie Haine, Martina Oneko, Muriel Debois, et al.
JAMA Oncology|September 28, 2019
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, Christina Fitzmaurice, Degu Abate, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2014
Molecular recognition and modification of the 30S ribosome by the aminoglycoside-resistance methyltransferase NpmAJack A Dunkle, Kellie Vinal, Pooja M Desai, et al.
The Journal of Antibiotics|September 15, 2011
New polyene macrolide family produced by submerged culture of Streptomyces durmitorensisEva Stodůlková, Marek Kuzma, Ivana Bratic Hench, et al.
The Lancet. Global Health|April 27, 2025
Incidence rates of malaria, meningitis, and mortality in children younger than 5 years: a prospective cohort study in Ghana and Kenya before the roll-out of the RTS,S/AS01<sub>E</sub> malaria vaccine from 2016 to 2022Kwaku Poku Asante, Marie-Cécile Bozonnat, Miloje Savic, et al.
Eclinicalmedicine|May 4, 2026
Feasibility, accuracy, and effect of a rapid point-of-care serological test (SeroSelectTB) to identify presumptive pulmonary TB patients for confirmatory testing in Ethiopia, South Africa, and Tanzania: a multicenter, open-label, parallel-group, randomized, controlled trialMiloje Savic, Grant Theron, Kidist Bobosha, et al.
The Lancet. Global Health|November 9, 2025
Effectiveness of the RTS,S/AS01<sub>E</sub> malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and MalawiLatif Ndeketa, Valérie Haine, Muriel Debois, et al.
The Lancet. Global Health|April 27, 2025
Safety of RTS,S/AS01<sub>E</sub> malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring studyValérie Haine, Martina Oneko, Muriel Debois, et al.
JAMA Oncology|September 28, 2019
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, Christina Fitzmaurice, Degu Abate, et al.
Pageof 3